EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Healthcare resource allocation for rare diseases: an exploratory survey of Swiss citizens’ preferences

Federico Germani iD, Giovanni Spitale, Carola Fischer iD, Brigitte Tag, Janine Reichenbach iD, Olivier Devuyst iD, Matthias Baumgartner iD, Nikola Biller-Andorno iD

Swiss Medical Weekly · 2025

DOI: 10.57187/s.4243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Swiss Medical Weekly, 2025. Verfasst von Federico Germani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Rare Diseases, Resource Allocation, Patient Preference, Health Care Rationing. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study explores how Swiss citizens prioritise healthcare resource allocation for rare diseases, considering variables such as disease rarity, treatment cost, patient age and treatment outcomes. METHODS: We conducted an exploratory survey using visual discrete-choice vignettes embedded in scenario cards. Each card depicted a fictional patient case based on real-world disease attributes. A total of 157 unique real-world scenarios were designed by combining variables such as rarity, age group, cost and impact on quality of life. Participants were asked whether they would recommend treatment funding for each scenario. RESULTS: A total of 375 participant responses were analysed. Our findings reveal that the probability of a positive decision to treat was influenced more by treatment effectiveness and quality-of-life outcomes than by disease rarity or cost. CONCLUSION: The results suggest that while high treatment costs do pose challenges, they are often secondary to the perceived benefits of treatment; Swiss citizens prioritise treatment effectiveness and quality-of-life improvements over rarity or treatment cost when considering funding decisions

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesResource AllocationPatient PreferenceHealth Care RationingHumansSwitzerlandMaleFemaleQuality of LifeMiddle AgedAdultAgedSurveys and QuestionnairesHealth Care CostsYoung AdultDecision MakingAdolescent

Autor:innen und Institutionen

  • Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland.
  • Department Somatic Gene Therapy, University Children's Hospital Zurich, Zurich, Switzerland.
  • Faculty of Law, University of Zurich, Zurich, Switzerland.
  • Division Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.
  • Centre for Applied Biotechnology and Molecular Medicine, University of Zurich, Zurich, Switzerland.
  • Institute of Physiology, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Federico Germani, Carola Fischer, Janine Reichenbach, Olivier Devuyst, Matthias Baumgartner, Nikola Biller-Andorno

Zitieren

APA

Germani, F., Spitale, G., Fischer, C., Tag, B., Reichenbach, J., Devuyst, O., Baumgartner, M., & Biller-Andorno, N. (2025). Healthcare resource allocation for rare diseases: an exploratory survey of Swiss citizens’ preferences. Swiss Medical Weekly. https://doi.org/10.57187/s.4243

Vancouver

Germani F, Spitale G, Fischer C, Tag B, Reichenbach J, Devuyst O, et al. Healthcare resource allocation for rare diseases: an exploratory survey of Swiss citizens’ preferences. Swiss Medical Weekly. 2025. doi:10.57187/s.4243

BibTeX
@article{Germani2025,
  author = {Germani, Federico and Spitale, Giovanni and Fischer, Carola and Tag, Brigitte and Reichenbach, Janine and Devuyst, Olivier and Baumgartner, Matthias and Biller-Andorno, Nikola},
  title = {Healthcare resource allocation for rare diseases: an exploratory survey of Swiss citizens’ preferences},
  journal = {Swiss Medical Weekly},
  year = {2025},
  doi = {10.57187/s.4243}
}
Kostenlos starten →